1. Home
  2. APYX vs CCEL Comparison

APYX vs CCEL Comparison

Compare APYX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.44

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.50

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
CCEL
Founded
1982
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.2M
32.7M
IPO Year
1987
1997

Fundamental Metrics

Financial Performance
Metric
APYX
CCEL
Price
$3.44
$3.50
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$7.00
N/A
AVG Volume (30 Days)
61.9K
4.3K
Earning Date
11-06-2025
10-15-2025
Dividend Yield
N/A
11.43%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,902,000.00
$31,747,500.00
Revenue This Year
$8.41
$0.30
Revenue Next Year
$7.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$3.45
52 Week High
$4.44
$8.79

Technical Indicators

Market Signals
Indicator
APYX
CCEL
Relative Strength Index (RSI) 38.77 38.36
Support Level $3.46 $3.58
Resistance Level $3.68 $3.99
Average True Range (ATR) 0.15 0.30
MACD -0.07 -0.04
Stochastic Oscillator 8.57 3.90

Price Performance

Historical Comparison
APYX
CCEL

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: